Cargando…
Hematopoietic Stem Cells in Type 1 Diabetes
Despite the increasing knowledge of pathophysiological mechanisms underlying the onset of type 1 diabetes (T1D), the quest for therapeutic options capable of delaying/reverting the diseases is still ongoing. Among all strategies currently tested in T1D, the use of hematopoietic stem cell (HSC)-based...
Autores principales: | Pastore, Ida, Assi, Emma, Ben Nasr, Moufida, Bolla, Andrea Mario, Maestroni, Anna, Usuelli, Vera, Loretelli, Cristian, Seelam, Andy Joe, Abdelsalam, Ahmed, Zuccotti, Gian Vincenzo, D’Addio, Francesca, Fiorina, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299361/ https://www.ncbi.nlm.nih.gov/pubmed/34305929 http://dx.doi.org/10.3389/fimmu.2021.694118 |
Ejemplares similares
-
Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns
por: Assi, Emma, et al.
Publicado: (2020) -
PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response
por: Loretelli, Cristian, et al.
Publicado: (2021) -
Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes
por: Ben Nasr, Moufida, et al.
Publicado: (2018) -
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy
por: D’Addio, Francesca, et al.
Publicado: (2022) -
miR‐21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
por: Usuelli, Vera, et al.
Publicado: (2021)